about
Chlamydia psittaci: update on an underestimated zoonotic agentChlamydiae interaction with the endoplasmic reticulum: contact, function and consequencesIn contrast to Chlamydia trachomatis, Waddlia chondrophila grows in human cells without inhibiting apoptosis, fragmenting the Golgi apparatus, or diverting post-Golgi sphingomyelin transportThe intracellular bacteria Chlamydia hijack peroxisomes and utilize their enzymatic capacity to produce bacteria-specific phospholipidsContrasting Lifestyles Within the Host CellPurification and proteomics of pathogen-modified vacuoles and membranesLipid exchange between Borrelia burgdorferi and host cellsProtochlamydia induces apoptosis of human HEp-2 cells through mitochondrial dysfunction mediated by chlamydial protease-like activity factorA novel co-infection model with Toxoplasma and Chlamydia trachomatis highlights the importance of host cell manipulation for nutrient scavengingLaser-mediated rupture of chlamydial inclusions triggers pathogen egress and host cell necrosis.Nitropropenyl benzodioxole, an anti-infective agent with action as a protein tyrosine phosphatase inhibitorUptake of biotin by Chlamydia Spp. through the use of a bacterial transporter (BioY) and a host-cell transporter (SMVT).Role for chlamydial inclusion membrane proteins in inclusion membrane structure and biogenesisGolgi fragmentation and sphingomyelin transport to Chlamydia trachomatis during penicillin-induced persistence do not depend on the cytosolic presence of the chlamydial protease CPAFChlamydia trachomatis Relies on Autonomous Phospholipid Synthesis for Membrane Biogenesis.Endoplasmic Reticulum Tubule Protein Reticulon 4 Associates with the Legionella pneumophila Vacuole and with Translocated Substrate Ceg9.The trans-Golgi SNARE syntaxin 10 is required for optimal development of Chlamydia trachomatis.Fierce competition between Toxoplasma and Chlamydia for host cell structures in dually infected cells.Chlamydial metabolism revisited: interspecies metabolic variability and developmental stage-specific physiologic activitiesChlamydia trachomatis growth and development requires the activity of host Long-chain Acyl-CoA Synthetases (ACSLs).Chlamydia trachomatis growth depends on eukaryotic cholesterol esterification and is affected by Acyl-CoA:cholesterol acyltransferase inhibitionChlamydia cell biology and pathogenesisSortilin is associated with the chlamydial inclusion and is modulated during infectionChlamydia trachomatis transports NAD via the Npt1 ATP/ADP translocase.Perforin-2 restricts growth of Chlamydia trachomatis in macrophagesGuinea pig genital tract lipidome reveals in vivo and in vitro regulation of phosphatidylcholine 16:0/18:1 and contribution to Chlamydia trachomatis serovar D infectivity.Lipid synthesis in protozoan parasites: a comparison between kinetoplastids and apicomplexansMetabolomics of the tick-Borrelia interaction during the nymphal tick blood meal.N-acylated derivatives of sulfamethoxazole block Chlamydia fatty acid synthesis and interact with FabF.Molecular cartography in acute Chlamydia pneumoniae infections--a non-targeted metabolomics approach.Targeting of the hydrophobic metabolome by pathogens.Changes in Lipid and Fatty Acid Composition During Intramacrophagic Transformation of Leishmania donovani Complex Promastigotes into Amastigotes.Chlamydia trachomatis regulates growth and development in response to host cell fatty acid availability in the absence of lipid droplets.Phosphatidylserine decarboxylase CT699, lysophospholipid acyltransferase CT775, and acyl-ACP synthase CT776 provide membrane lipid diversity to Chlamydia trachomatis.Chlamydia trachomatis Is Responsible for Lipid Vacuolation in the Amniotic Epithelium of Fetal GastroschisisTherapeutic Targets in Chlamydial Fatty Acid and Phospholipid Synthesis
P2860
Q26823750-07FDBDE1-C2CA-4E15-A516-849505157CF7Q27014662-0173C077-616B-490A-9251-EE46DEE5BE73Q27322698-EB5DEB63-337C-4005-8779-88AA058E424CQ27331699-1CFD5BD2-0FF5-4DDB-A307-81F143E1BA3DQ28078686-A3EF44C0-56C2-4AB3-B772-2F21A1EC1A6CQ28080622-B824015D-8216-4ECF-B888-EAE30715E4C1Q28484938-DFFD589E-2B47-40CF-8697-95298A6D179FQ28486103-471D28EF-4D96-4A8A-B5BF-C01CD768AD6CQ30538838-A4765DD6-A532-4A06-9815-5F33702F3CA8Q30842037-3A354FF8-7FC9-4E07-B005-1ECD57175215Q33815443-184D3FA6-ABB2-4CD1-A370-0DA59C340805Q34430716-576C05F2-96F0-44F1-993C-70D163B7E09DQ34733854-3306F319-BE53-4260-8600-7AEA8F1DA250Q35214207-50B65FAD-ECE8-4FAC-BE75-8578A9E552F4Q35905277-1FF53640-F185-47BF-8C51-9B42D71101BAQ35947390-718E2031-0362-4C76-BDE7-17A5821F45DFQ36098055-5A45D56C-1DC0-437B-8EAB-CB79D4367629Q36606877-8859A02E-C3FA-40BD-A7CC-BC74505E871AQ36683752-894AE122-CF9E-482F-AAE8-469DC1499300Q36700046-817FA355-2D55-41AD-A8F5-7F6D0A734F83Q36855075-26AB8AD5-F69F-46B7-B96E-AE846FE3958FQ36950792-BD5C8448-9504-4D5F-AD74-60BC83766C0CQ36961399-9AA2733C-D47D-4EFB-9B45-68BEE950A543Q37035936-B028CF58-E527-4762-B39A-8C0898B31274Q37035953-6FF50BA9-F516-40C0-8A6C-E7D107D510D9Q37255052-F0AD2CEB-29EF-430E-B5FC-FE91AA8B41AFQ37315680-05FF0E14-BEFC-4D07-ADC2-F6D5B97F8010Q37695689-A8310EC0-6EDE-44CD-AEBC-92E45119AB19Q37833685-5BBCD746-3C12-4E84-B2A4-A5FC0543A459Q37847213-39364429-6727-4044-95D9-2510572A3AFAQ38371073-FEFA03B8-0284-4001-8D1C-BC8C32896884Q40345051-1A71FF9D-4C9A-49F9-BC77-4AB634154DB6Q44059252-DE42D2D4-5E21-4FD2-AF30-EDCA0BD6D366Q44059365-EF069CCC-A131-4EB0-822D-158210C6C290Q56243407-1FCD3403-32F0-4B3B-8810-FA2F679D5C13Q57492054-345D4E13-FF67-49FF-AE20-B3302C8F47C0
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 April 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lipid acquisition by intracellular Chlamydiae.
@en
Lipid acquisition by intracellular Chlamydiae.
@nl
type
label
Lipid acquisition by intracellular Chlamydiae.
@en
Lipid acquisition by intracellular Chlamydiae.
@nl
prefLabel
Lipid acquisition by intracellular Chlamydiae.
@en
Lipid acquisition by intracellular Chlamydiae.
@nl
P2860
P1476
Lipid acquisition by intracellular Chlamydiae.
@en
P2093
Cherilyn A Elwell
Joanne N Engel
P2860
P304
P356
10.1111/J.1462-5822.2012.01794.X
P577
2012-04-17T00:00:00Z